Menu
Fechar
hrs4r
 I want to donate

BEGOÑA MARTIN CASTILLO

Metabolism and Cancer
Scientific platforms staff
Firma
BEGOÑA MARTIN-CASTILLO
Position
Investigador/a Consolidat - R3
Established Researchers - R3
Projectes
Publicacions

Projectes

Radiation Oncology and Medical Physics of Girona

Linfadenectomía axilar versus radioterapia axilar en pacientes con ganglio centinela positivo tras terapia neodyuvante. Estudio multicéntrico randomizado fase III.

Codi oficial: ADARNAT I Start date:09/12/2022 Data fi: 09/12/2027 Investigador/a principal: ARANTXA ERASO URIÉN Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER Ajuda: 0 €

Publicacions

0

Metformin and breast cancer: an opportunity for pharmacogenetics

Aging-Us, 2022, 14, 5612-5613 dx.doi.org/10.18632/aging.204180
0

Metformin and Breast Cancer: Where Are We Now?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 dx.doi.org/10.3390/ijms23052705

Tramonti A, Cuyàs E, Encinar JA, Pietzke M, Paone A, Verdura S, Arbusà A, Martin-Castillo B, Giardina G, Joven J, Vazquez A, Contestabile R, Cutruzzolà F, Menendez JA

Metformin Is a Pyridoxal-5'-phosphate (PLP)-Competitive Inhibitor of SHMT2.

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13164009

Cuyàs E, Verdura S, Martin-Castillo B, Menendez JA

Metformin: Targeting the Metabolo-Epigenetic Link in Cancer Biology.

Frontiers in oncology, 2021, 10, 620641-620641 dx.doi.org/10.3389/fonc.2020.620641

Bosch-Barrera J, Roqué A, Teixidor E, Carmona-Garcia MC, Arbusà A, Brunet J, Martin-Castillo B, Cuyàs E, Verdura S, Menendez JA

Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin.

Pharmaceuticals, 2021, 15 dx.doi.org/10.3390/ph15010019

Cuyàs E, Verdura S, Martin-Castillo B, Alarcón T, Lupu R, Bosch-Barrera J, Menendez JA

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy.

Cancers, 2020, 12 dx.doi.org/10.3390/cancers12071757

Cuyàs E, Gumuzio J, Verdura S, Brunet J, Bosch-Barrera J, Martin-Castillo B, Alarcón T, Encinar JA, Martin ÁG, Menendez JA

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.

Aging-Us, 2020, 12, 4794-4814 dx.doi.org/10.18632/aging.102887

Verdura S, Cuyàs E, Cortada E, Brunet J, Lopez-Bonet E, Martin-Castillo B, Bosch-Barrera J, Encinar JA, Menendez JA

Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.

Aging-Us, 2020, 12, 8-34 dx.doi.org/10.18632/aging.102646

Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA

Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.

Journal of Clinical Medicine, 2020, 9 dx.doi.org/10.3390/jcm9061770

Cuyàs E, Gumuzio J, Lozano-Sánchez J, Segura-Carretero A, Verdura S, Bosch-Barrera J, Martin-Castillo B, Nonell-Canals A, Llebaria A, Cabello S, Serra C, Sanchez-Martinez M, Martin ÁG, Menendez JA

Mimetics of extra virgin olive oil phenols with anti-cancer stem cell activity.

Aging-Us, 2020, 12, 21057-21075 dx.doi.org/10.18632/aging.202154

Formulari de contacte

About IDIBGI!

 menu